Emmaus Life Sciences Inc
(EMMA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,389 | 2,547 | 2,021 | 2,279 | 2,487 |
| Receivables | 2,623 | 5,524 | 375 | 1,040 | 198 |
| Inventories | 1,635 | 1,711 | 2,379 | 4,392 | 7,087 |
| TOTAL | $6,767 | $11,509 | $6,289 | $9,091 | $11,257 |
| Non-Current Assets | |||||
| PPE Net | 46 | 59 | 75 | 147 | 120 |
| Investments And Advances | 15,037 | 20,978 | 38,799 | 43,716 | 43,791 |
| Other Non-Current Assets | 1,752 | 2,633 | 3,062 | 3,780 | 4,368 |
| TOTAL | $16,835 | $23,670 | $41,936 | $47,643 | $48,279 |
| Total Assets | $23,602 | $35,179 | $48,225 | $56,734 | $59,536 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 162 | 451 | 3,248 | 400 | 6,280 |
| Accounts payable and accrued liabilities | 16,926 | 16,951 | 13,549 | 9,189 | 7,460 |
| Other current liabilities | 16,565 | 14,746 | 12,987 | 5,907 | 3,770 |
| TOTAL | $63,555 | $61,507 | $54,323 | $37,100 | $23,382 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | 380 | 1,500 | 222 |
| Other Non-Current Liabilities | 16,526 | 21,428 | 27,613 | 39,584 | 41,090 |
| TOTAL | $16,526 | $21,428 | $27,993 | $41,084 | $41,312 |
| Total Liabilities | $80,081 | $82,935 | $82,316 | $78,184 | $64,694 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 63,866 | 61,846 | 50,935 | 49,312 | 49,312 |
| Common Shares | 64 | 62 | 50 | 49 | 49 |
| Retained earnings | -262,575 | -256,122 | -252,337 | -241,266 | -225,079 |
| Other shareholders' equity | -19,864 | -17,029 | -2,619 | -255 | 1,144 |
| TOTAL | $-56,479 | $-47,756 | $-34,091 | $-21,450 | $-5,158 |
| Total Liabilities And Equity | $23,602 | $35,179 | $48,225 | $56,734 | $59,536 |